Short-term Cardio-Vascular Risk Score Changes in Type 2 Diabetic Patients on Empaglifozin: A Real-Life Clinical Experience
Journal Title: Heart Research – Open Journal - Year 2017, Vol 4, Issue 3
Abstract
Objective: The aim of the study was to test both efficacy and safety of empaglifozin in type 2 diabetic out patients followed-up within a single institution. Materials and Methods: One hundred seventy-eight consecutive patients treated with empaglifozin for 6 months were compared to 356 fully matched control patients on alternative drugs: side effects were monitored and changes from baseline were evaluated for body weight, body mass index (BMI), blood pressure, circulating glucose, HbA1c, uric acid, triglycerides, total, high density lipoprotein (HDL) and low density lipoprotein (LDL)-cholesterol levels, as well as creatinine clearance rate. The 10-year Cardiovascular Risk score (10-y CV-RS) was also assessed in all patients according to the cryogenic underground observatory for rare events (CUORE) calculation charts. Weight, BMI, systolic and diastolic blood pressure, as well as, HbA1c, glucose, cholesterol, triglyceride and uric acid levels, significantly decreased after treatment, along with the 10-y CV-RS which is in fact strongly related to the above. Results: Virtually no changes were observed in creatinine clearance rate and HDL levels. 45% patients reported polyuria, 15% genital itching, 8% genital infections, 12% urinary tract infections, no volume depletion or keto-acidosis episodes were described. Conclusion: In conclusion, in diabetic patients experiencing no previous major cardiovascular events, empaglifozin significantly improved all cardiovascular risk factors, including glucose control, and the 10-y CV-RS. Moreover it was well tolerated, so that no treatment discontinuation was needed even in case of urinary tract infections.
Authors and Affiliations
Sandro Gentile
Keywords
Related Articles
- EP ID EP557960
- DOI 10.17140/HROJ-4-141
- Views 107
- Downloads 0
Pharmacological Agents in the Clinic: Trial and Error
Following an explosion of molecular and cellular research in the last 50 years, the study of specific molecular targets in the context of heart failure has generated much excitement. With the incidence of heart failure r...
Visual Processing Disorder in Children
The minute persons think of eyesight, they generally think about accuracy, as in normal, 6/6 (or 20/20) vision. However, it is much more than that as the brain really processes the visual world, including things like sym...
The Effect of Intranasal Pressure on Intraocular Pressure
Purpose: The aim of this study was to evaluate intraocular pressure (IOP) after the application of the nasal packing for sinonasal surgery. Methods:A total of 40 patients who underwent sinonasal surgery were enrolled in...
Cardiac Telerehabilitation - Current State and Clinical Perspectives
Cardiovascular Diseases (CVD) are regarded as a leading cause of death globally, constituting important medical, social and economical problem. Systematic reviews and metaanalyses show the positive effect of exercise-bas...
Forgotten, but Not Gone
A 65 year old woman, an Asian immigrant to USA, with the history of surgical mitral valvuloplasty through left thoracotomy performed 30 years ago in India for severe rheumatic mitral stenosis, history of embolic occlusio...